Director/PDMR Shareholding

Summary by AI BETAClose X

On September 5, 2025, Judges Scientific plc announced that the Trustees of the Share Incentive Plan purchased ordinary shares for several of its directors/PDMRs. David Cicurel, the CEO, Bradley Ormsby, the CFO, Mark Lavelle, the COO, Tim Prestidge, the Group Business Development Director, and Ian Wilcock, the Group Commercial Director, were each involved in the purchase. For each director/PDMR, the Trustees purchased 6 shares at a price of 6275.0p per share on the London Stock Exchange, AIM Market (XLON). These were initial notifications of the transactions.

Disclaimer*

UK 100

Latest directors dealings